Literature DB >> 15172963

Epidermal growth factor differentially augments G(i)-mediated stimulation of c-Jun N-terminal kinase activity.

Anthony S L Chan1, Yung H Wong.   

Abstract

1. Signaling networks involving different receptor systems allow extracellular signals to be integrated and transformed into various biological activities. In this report, we studied the activity of the c-Jun N-terminal kinase (JNK) subgroup of mitogen-activated protein kinases (MAPKs), in response to stimulation by G protein-coupled receptors (GPCRs) and co-activation with epithermal growth factor receptor (EGFR). 2. Stimulation of exogenous GPCRs in Cos-7 cells induced JNK activation of different magnitudes depending on their G-protein coupling specificities (G(q)>G(i)>G(s)), and a moderate JNK activation was linked to stimulation of endogenous EGFR by EGF. 3. Co-stimulation with GPCR agonists and EGF resulted in differential augmentation of JNK activities, with G(i)-coupled receptors associated with a synergistic JNK activation upon co-stimulation with EGF, while G(q)- and G(s)-coupled receptors were incapable of triggering this effect. 4. This G(i)/EGF-induced synergistic JNK activation was inhibited by pertussis toxin and AG1478, and may involve Src family tyrosine kinases, PI3 K, Ca(2+)/calmodulin and small GTPases as important intermediates, while Ca(2+) mobilization was triggered by the stimulation of G(q)-coupled receptor or EGF treatment, but not by the G(i)- or G(s)-coupled receptors. 5. Transient expression of Gbetagamma subunits with EGF treatment, or co-activation of exogenous G(i)-coupled receptor with thapsigargin also resulted in a synergistic JNK activation. Activation of G(i)-coupled receptor accompanied with EGF treatment enhanced the expression level and activity of MAPK phosphatase type I, which occurred after the maximal synergistic JNK activation. 6. Our results support a mechanistic model where EGF signaling may differentially regulate the JNK activities triggered by GPCRs of different coupling specificities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172963      PMCID: PMC1575057          DOI: 10.1038/sj.bjp.0705851

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Crosstalk between Galpha(i)- and Galpha(q)-coupled receptors is mediated by Gbetagamma exchange.

Authors:  U Quitterer; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway.

Authors:  S K Logan; M Falasca; P Hu; J Schlessinger
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  The mouse GalR2 galanin receptor: genomic organization, cDNA cloning, and functional characterization.

Authors:  L Pang; T Hashemi; H J Lee; M Maguire; M P Graziano; M Bayne; B Hawes; G Wong; S Wang
Journal:  J Neurochem       Date:  1998-12       Impact factor: 5.372

4.  Induction of rac-guanine nucleotide exchange activity of Ras-GRF1/CDC25(Mm) following phosphorylation by the nonreceptor tyrosine kinase Src.

Authors:  M Kiyono; Y Kaziro; T Satoh
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

5.  EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF.

Authors:  N Prenzel; E Zwick; H Daub; M Leserer; R Abraham; C Wallasch; A Ullrich
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

6.  Phosphoinositide 3-kinase-dependent and -independent activation of the small GTPase Rac2 in human neutrophils.

Authors:  T Akasaki; H Koga; H Sumimoto
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

7.  Phosphoinositide 3-kinase gamma is a mediator of Gbetagamma-dependent Jun kinase activation.

Authors:  M Lopez-Ilasaca; J S Gutkind; R Wetzker
Journal:  J Biol Chem       Date:  1998-01-30       Impact factor: 5.157

8.  c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function.

Authors:  J S Biscardi; M C Maa; D A Tice; M E Cox; T H Leu; S J Parsons
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

9.  A novel role for phosphatidylinositol 3-kinase beta in signaling from G protein-coupled receptors to Akt.

Authors:  C Murga; S Fukuhara; J S Gutkind
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

10.  Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation.

Authors:  B C Paria; K Elenius; M Klagsbrun; S K Dey
Journal:  Development       Date:  1999-05       Impact factor: 6.862

View more
  4 in total

1.  Activation of A431 human carcinoma cell motility by extracellular high-mobility group box 1 protein and epidermal growth factor stimuli.

Authors:  Bianca Sparatore; Mauro Patrone; Mario Passalacqua; Marco Pedrazzi; Sabina Ledda; Sandro Pontremoli; Edon Melloni
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

2.  Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression.

Authors:  David C New; Yung H Wong
Journal:  J Mol Signal       Date:  2007-02-26

3.  Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells.

Authors:  Kate Chao-Wei Chen; You Zhou; Wei Zhang; Marjorie F Lou
Journal:  Mol Vis       Date:  2007-03-14       Impact factor: 2.367

4.  Epidermal growth factor potentiates in vitro metastatic behaviour of human prostate cancer PC-3M cells: involvement of voltage-gated sodium channel.

Authors:  Pinar Uysal-Onganer; Mustafa Ba Djamgoz
Journal:  Mol Cancer       Date:  2007-11-24       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.